James P. Allison, 2018 Nobel Laureate in Physiology or Medicine, and IRIS CEO Simon Chin

On October 1, 2018, the Nobel Assembly decided to award the 2018 Nobel Prize in Physiology or Medicine jointly to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation. Their seminal discoveries constitute a landmark in the fight against cancer. Dr. Alison served at UC Berkeley as a professor of molecular and cell biology and director of the Cancer Research Laboratory from 1985 – 2004. He is the Chair of the Department of Immunology and the Executive Director of the Immunotherapy Platform at MD Anderson, which is ranked as the #1 Cancer Center in the US.

Health and Wellness Experts

Michael Roizen, MD is the Chief Wellness Officer at the Cleveland Clinic.  Dr. Elissa Epel, a UCSF Professor in Psychiatry, is the Director of the Aging, Metabolism, and Emotions Center, and the Consortium for Obesity Assessment, Study, & Treatment.  Dean Ornish, MD, a UCSF Professor in Medicine, is the author of Dr. Dean Ornish’s Program for Reversing Heart Disease, Eat More, Weigh Less and The Spectrum.  Beverly Maloney-Fishback is the CEO, Founder & Publisher of Organic Spa Media, LTD.  Dr. Jay Williams is an acclaimed physiologist and medical nutritionist, author, researcher, and health and wellness consultant. Simon Chin is the President & CEO of IRIS Wellness Labs.

Frost and Sullivan North American Technology Innovation Award in Pharmacology

Frost and Sullivan, in recognizing IRIS Wellness Labs’ parent company, IRIS Biotechnologies, with their Award in Pharmacology, stated “For patients, this technology would be pivotal in yielding a personalized treatment regimen, with the greatest possibility of success, for each individual patient’s particular type of disease such as cancer, heart disease, diabetes, or gene-related metabolic disorders.”  IRIS Wellness Labs was launched based upon this and other technologies.

World's Largest Gathering for Laboratory Medicine at AACC

At the American Association for Clinical Chemistry conference (AACC), IRIS CEO Simon Chin was a panelist discussing the integration of data for computational and clinical outcomes.

According to AACC, this is “a panel drawn from the healthcare professionals and diagnostic industry leaders who have a vision for how this innovation evolution might look and insight into what laboratorians and IVD manufacturers may expect. Since the laboratory produces an overwhelming amount of data that challenges today’s legacy architecture, the future which will include extensive data arrays drawn from next generation sequencing and companion diagnostics, call for contemporary tools and systems to deliver the promise of tomorrow’s world.”

The panel was moderated by Bob McGonnagle, the Publisher of the College of American Pathologists trade journal, CAPToday.  Mr. McGonnagle invited Mr. Chin to speak at AACC after Mr. McGonnagle heard Mr. Chin’s invited presentation at BIO, the world’s largest biotech conference.

Mr. Chin has four patents, including, US patent 8,693,751, “Artificial Intelligence System for Genetic Analysis.”  He has been on the University of Pacific’s Thomas J. Long School of Pharmacy and Health Sciences Industrial Advisory Board for six years.  The board includes key people from Novartis, Gilead, Supergen, Exact Sciences, UC Berkeley, and other entities.

IRIS Wellness Labs Doctor, Charles Wiseman, MD, and IRIS CEO Simon Chin

IRIS Scientific Advisory Board

We are delighted that an eminently qualified scientific advisory board guides our parent company, which then support us with medical and scientific advice, patents, and leading-edge technoloogy development.  IRIS Biotechnologies’ scientific advisory board includes Professor Walter Hittelman at M.D. Anderson Cancer Center, Professor Wei Zhang at Wake Forest School of Medicine, Professor Weidong Le, MD, PhD, at Baylor College of Medicine, Professor Norman Tien, University of Hong Kong’s Dean of the Faculty of Engineering, and Charles Wiseman, MD, a Beverly Hills oncologist and immunologist, who is also on IRIS Wellness Labs medical team.

American Society of Clinical Oncology (ASCO) Conference: Simon Chin and Laura Esserman, MD

Dr. Laura Esserman, a practicing surgeon, professor of Surgery and Radiology, a faculty member, practicing surgeon, breast cancer oncology specialist and the director at UCSF ‘Carol Franc Buck’ Breast Care Center has been at the forefront of efforts to change the delivery of breast cancer services as well as information systems used to support both research and patient care.

$3 million Breakthrough Prize Winner Dr. Jennifer Doudna and IRIS CEO Simon Chin

Dr. Jennifer Anne Doudna, a Biochemist and Professor at the University of California, Berkeley won the $3 million Breakthrough Prize for her work on a gene editing method called CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats).  CRISPR/Cas genome editing techniques have many potential applications in medicine and other areas.

Nobel Laureate and Former President of the Howard Hughes Medical Institute, Dr. Thomas Cech and IRIS CEO Simon Chin at HHMI

Dr. Thomas Robert Cech received the 1989 Nobel Prize in Chemistry with Sidney Altman, for their discovery of the catalytic properties of RNA. As president of Howard Hughes Medical Institute, he promoted science education.   Dr. Cech completed his PhD in Chemistry at the University of California, Berkeley.

Simon Chin, Susie Ellis with Dr. Richard Carmona

IRIS CEO Simon Chin, GWS CEO Susie Ellis, and Former US Surgeon General Dr. Richard Carmona at the Global Wellness Summit.

Recognized as one of the leading authorities on the multi-sector wellness industry, Susie Ellis is currently the chairman and CEO of the Global Wellness Institute (GWI), and heads up the organization’s annual Global Wellness Summit and Global Wellness Tourism Congress.

Dr. Richard Henry Carmona was the seventeenth Surgeon General of the United States and is now the vice chairman of the Canyon Ranch resort, President of the non-profit Canyon Ranch Institute, and a professor at the Mel and Enid Zuckerman College of Public Health at the University of Arizona.

Simon Chin, Dr. Oz and Susie Ellis

Simon Chin (founder and CEO of IRIS Wellness Labs), with Dr. Oz and Susie Ellis at the Global Wellness Summit.

Dr. Oz (Mehmet Cengiz Öz), a cardiothoracic surgeon and professor at Columbia University is also a well known best-selling author and television personality.  His philosophy is to take away the barriers between the patient and their medicine. The Dr. Oz Show, a daily television program, focuses on medical issues and personal health.

Susie Ellis is recognized as one of the leading authorities on the multi-sector wellness industry, she is currently the chairman and CEO of the Global Wellness Institute (GWI), and heads up the organization’s annual Global Wellness Summit and Global Wellness Tourism Congress.

Susie Ellis, Dr. Andrew Weil and Simon Chin

Andrew Weil, MD is a Lovell-Jones Professor of Integrative Rheumatology, Clinical Professor of Medicine, and Professor of Public Health at the University of Arizona. He is a leader and pioneer in the field of integrative medicine, a healing oriented approach to health care—which encompasses body, mind, and spirit.

IRIS CEO Simon Chin Running the Napa Valley Marathon

IRIS CEO Simon Chin ran 26.2 miles to raise fund for the Leukemia and Lymphoma Society. Mr. Chin believes in giving back to society. He served on the advisory board of Santa Clara University’s Ignatian Center for Jesuit Education for 11 years, on the board of directors of the YMCA of Silicon Valley, which serves a million people through its 12 branches in Santa Clara County for 6 years, and as a member of the Saratoga Rotary Club for 18 years helping people all over the world.